Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
Biomedical research has been revolutionized by the introduction of many CRISPR-Cas systems that induce programmable edits to nearly any gene in the human genome.
A new gene editing service provides researchers on campus with genetically engineered pluripotent stem cell lines derived using CRISPR-Cas9. The UW-Madison iPSC Reprogramming and Human Stem Cell Gene Editing Service is co-operated by the Waisman Center’s iPSC Core and led by investigators Anita Bhattacharyya and Su-Chun Zhang. The techniques and expertise that keep the service …
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
An innovative project led by Waisman Center researchers Anita Bhattacharyya and Su-Chun Zhang is one of fourteen research initiatives that have been chosen for the first round of funding by the University of Wisconsin-Madison Office of the Vice Chancellor for Research and Graduate Education for the UW2020: WARF Discovery Initiative.
Applying a dramatically improved method for “editing” genes to human stem cells, University of Wisconsin-Madison neuroscientist and Waisman Center investigator Su-Chun Zhang has shown a new way to silence genes in stem cells and their progeny at any stage of development.
